Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : T/FIF Portfolio -- Ignore unavailable to you. Want to Upgrade?

To: Larry Liebman who wrote (434)	1/19/1999 7:22:00 AM
From: Mike McFarland	Respond to of 1073

Larry, hasn't medi become a bit of a momentum play with the split and all... I'm not saying it wont run some more, after all the last two times coverage was initiated, they were both buys... However, since SmithKline Beecham Biologicals received their approval for LYMErix, and with a third of medi's clinical work going into MEDI-507/BTI-322, I wonder if it might be time to start averaging out of that position... and into something that trades a little closer to book value... I want to meet the fellow who was clever enough to ride the big caps or the DOW through most of the 90's...then last summer he saw world markets unraveling and raised cash, only to put it to work this past fall into some second tier biotech, your MEDI, SEPR, or even something bigger like Biogen which also doubled last fall, sigh. But will that smart guy have the guts to take the third tier dive? A triple somersault which straightens out just in time for a perfect entry and no splash? Or will the crowd watch the internuts bellyflop and start a panic which tramples everyone? The tree thread is a great idea, but knowing when to execute the plan is tricky, I just went for buy and hold. Still holding my third tier. --Mike